A Phase II Study of Photodynamic Therapy (PDT) With LEVULAN (RM) Topical Solution + Blue Light Versus LEVULAN (RM) Topical Solution Vehicle + Blue Light for the Treatment of Actinic Keratoses on the Upper Extremities
Phase of Trial: Phase II
Latest Information Update: 13 Mar 2013
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 05 Mar 2013 Results presented at the 71st Annual Meeting of the American Academy of Dermatology.
- 01 Feb 2013 Primary endpoint amended as reported by ClinicalTrials.gov.
- 02 Aug 2012 Treatment has been completed and DUSA Pharmaceuticals expects to report interim results before the end of the third quarter of 2012.